ARGOS THERAPEUTICS INC's ticker is ARGSXXXX and the CUSIP is 040221103. A total of 25 filers reported holding ARGOS THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $406,000 | -55.9% | 82,850 | -55.2% | 0.27% | -14.6% |
| Q3 2016 | $920,000 | -18.9% | 185,097 | 0.0% | 0.31% | -30.8% |
| Q2 2016 | $1,135,000 | -8.8% | 185,097 | -4.8% | 0.45% | -12.0% |
| Q1 2016 | $1,244,000 | +108.7% | 194,400 | -24.6% | 0.52% | +207.1% |
| Q4 2015 | $596,000 | -52.1% | 257,900 | 0.0% | 0.17% | -29.4% |
| Q3 2015 | $1,243,000 | -60.2% | 257,900 | -43.5% | 0.24% | -19.3% |
| Q2 2015 | $3,127,000 | -24.5% | 456,500 | -1.8% | 0.30% | -24.6% |
| Q1 2015 | $4,142,000 | -12.8% | 464,900 | -2.1% | 0.39% | -14.3% |
| Q4 2014 | $4,751,000 | -0.6% | 475,100 | 0.0% | 0.46% | -7.5% |
| Q3 2014 | $4,780,000 | +13.9% | 475,100 | -9.1% | 0.49% | +36.9% |
| Q2 2014 | $4,196,000 | -19.0% | 522,500 | +0.9% | 0.36% | -14.9% |
| Q1 2014 | $5,178,000 | – | 517,800 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pharmstandard International S.A. | 13,242,279 | $64,887,000 | 55.88% |
| Pharmstandard International S.A. | 5,120,604 | $27,390,000 | 23.59% |
| SANDERS MORRIS HARRIS LLC | 292,512 | $1,433,000 | 0.66% |
| WALL STREET ASSOCIATES | 82,850 | $406,000 | 0.27% |
| WASATCH ADVISORS LP | 3,254,211 | $15,946,000 | 0.24% |
| ALTRINSIC GLOBAL ADVISORS LLC | 172,505 | $845,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 121,524 | $595,000 | 0.01% |
| Alyeska Investment Group, L.P. | 200,000 | $980,000 | 0.01% |
| Acrospire Investment Management LLC | 1,800 | $9,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1,024,428 | $5,020,000 | 0.00% |